Genetics of non-alcoholic fatty liver disease and associated metabolic disorders

Avances en Diabetologia

Volumn 27, Issue 6, 2011, Pages 186-197

  Hernaez, Ruben ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Fatty liver; Genetic association studies; Insulin resistance; Non alcoholic fatty liver disease; Obesity; Review

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CD14 ANTIGEN; COMPLEMENT COMPONENT C1Q; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID BINDING PROTEIN 2; GLUCOKINASE; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; LIVER TRIACYLGLYCEROL LIPASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MANGANESE SUPEROXIDE DISMUTASE; MELANOCORTIN 4 RECEPTOR; METHYLTRANSFERASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLETHANOLAMINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SERINE PROTEINASE INHIBITOR; SQUALENE SYNTHASE; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR CLOCK; TUMOR NECROSIS FACTOR ALPHA;

DISEASE COURSE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC TRAIT; HEMOCHROMATOSIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER METABOLISM; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; STEATOSIS;

EID: 84857364390     PISSN: 11343230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avdiab.2011.11.004     Document Type: Short Survey

References (152)

1. M. Lazo, and J.M. Clark The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin Liver Dis 28 2008 339 350
2. E.M. Brunt Nonalcoholic steatohepatitis: definition and pathology Semin Liver Dis 21 2001 3 16 (Pubitemid 32240482)
3. A.J. Sanyal AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 2002 1705 1725 (Pubitemid 35231670)
4. A.K. Daly, S. Ballestri, L. Carulli, P. Loria, and C.P. Day Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease Expert Rev Gastroenterol Hepatol 5 2011 253 263
5. D. Moreno-Sanchez [Epidemiology and natural history of primary nonalcoholic fatty liver disease] Gastroenterol Hepatol 29 2006 244 254
6. M.U. Jakobsen, T. Berentzen, T.I. Sorensen, and K. Overvad Abdominal obesity and fatty liver Epidemiol Rev 29 2007 77 87 (Pubitemid 47229638)
7. G. Pagano, G. Pacini, G. Musso, R. Gambino, F. Mecca, and N. Depetris Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association Hepatology 35 2002 367 372 (Pubitemid 34106376)
8. M. Hamaguchi, T. Kojima, N. Takeda, T. Nakagawa, H. Taniguchi, and K. Fujii The metabolic syndrome as a predictor of nonalcoholic fatty liver disease Ann Intern Med 143 2005 722 728
9. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, and M. Lenzi Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850 (Pubitemid 33641605)
10. F. Angelico, B.M. Del, R. Conti, S. Francioso, K. Feole, and S. Fiorello Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease J Clin Endocrinol Metab 90 2005 1578 1582 (Pubitemid 40464021)
11. G. Targher, L. Bertolini, R. Padovani, S. Rodella, R. Tessari, and L. Zenari Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients Diabetes Care 30 2007 1212 1218 (Pubitemid 46684650)
12. P. Angulo, J.C. Keach, K.P. Batts, and K.D. Lindor Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356 1362
13. G.C. Farrell, and C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 432Suppl1 2006 S99 S112
14. L. Caballeria, G. Pera, M.A. Auladell, P. Toran, L. Munoz, and D. Miranda Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain Eur J Gastroenterol Hepatol 22 2010 24 32
15. M.F. Abdelmalek, C. Liu, J. Shuster, D.R. Nelson, and N.R. Asal Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 4 2006 1162 1169 (Pubitemid 44311647)
16. I.R. Willner, B. Waters, S.R. Patil, A. Reuben, J. Morelli, and C.A. Riely Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease Am J Gastroenterol 96 2001 2957 2961 (Pubitemid 32959539)
17. M.C. Brouwers, M.M. Van Greevenbroek, and R.M. Cantor Heritability of nonalcoholic fatty liver disease Gastroenterology 137 2009 1536
18. J.B. Schwimmer, M.A. Celedon, J.E. Lavine, R. Salem, N. Campbell, and N.J. Schork Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
19. N. Chalasani, X. Guo, R. Loomba, M.O. Goodarzi, T. Haritunians, and S. Kwon Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease Gastroenterology 139 2010 1567 1576
20. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
21. E.K. Speliotes, L.M. Yerges-Armstrong, J. Wu, R. Hernaez, L.J. Kim, and C.D. Palmer Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits PLoS Genet 7 2011 e1001324
22. X. Yuan, D. Waterworth, J.R. Perry, N. Lim, K. Song, and J.C. Chambers Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 2008 520 528
23. F. Caballero, A. Fernandez, A.M. De Lacy, J.C. Fernandez-Checa, J. Caballeria, and C. Garcia-Ruiz Enhanced free cholesterol SREBP-2 and StAR expression in human NASH J Hepatol 50 2009 789 796
24. N. Guillen, M.A. Navarro, C. Arnal, E. Noone, J.M. Rbones-Mainar, and S. Acin Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver Physiol Genomics 37 2009 187 198
25. M.E. Miquilena-Colina, E. Lima-Cabello, S. Sanchez-Campos, M.V. Garcia-Mediavilla, M. Fernandez-Bermejo, and T. Lozano-Rodriguez Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C Gut 60 2011 1394 1402
26. M. Yoneda, H. Endo, H. Mawatari, Y. Nozaki, K. Fujita, and T. Akiyama Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis Hepatol Res 38 2008 1204 1212
27. Z.M. Younossi, A. Baranova, K. Ziegler, G.L. Del, K. Schlauch, and T.L. Born A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease Hepatology 42 2005 665 674 (Pubitemid 41233660)
28. D.T. Thomas Statistical methods in genetic epidemiology 1st ed. 2004 Oxford University Press New York
29. C.P. Day Genetic studies to identify hepatic fibrosis genes and SNPs in human populations Methods Mol Med 117 2005 315 331
30. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
31. R. Bataller, K.E. North, and D.A. Brenner Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal Hepatology 37 2003 493 503 (Pubitemid 36258768)
32. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insights Science 332 2011 1519 1523
33. A.J. Sanyal Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease Nat Clin Pract Gastroenterol Hepatol 2 2005 46 53 (Pubitemid 40812527)
34. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, and E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 2005 1343 1351 (Pubitemid 40629054)
35. Q.M. Anstee, A.K. Daly, and C.P. Day Genetics of alcoholic and nonalcoholic Fatty liver disease Semin Liver Dis 31 2011 128 146
36. HUGO Gene Nomenclature Committee at the European Bioinformatics Institute. HUGO Gene Nomenclature Committee (HGNC) [consultado 28 Jul 2011]. Disponible en: http://www genenames org.
37. R. Hernaez, E. Yeung, J.M. Clark, K.V. Kowdley, F.L. Brancati, and W.H. Kao Hemochromatosis gene and nonalcoholic fatty liver disease: A systematic review and meta-analysis J Hepatol 55 2011 1079 1085
38. N. Soranzo, S. Sanna, E. Wheeler, C. Gieger, D. Radke, and J. Dupuis Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways Diabetes 59 2010 3229 3239
39. Y. Huang, S. He, J.Z. Li, Y.K. Seo, T.F. Osborne, and J.C. Cohen A feed-forward loop amplifies nutritional regulation of PNPLA3 Proc Natl Acad Sci U S A 107 2010 7892 7897
40. S. Sookoian, and C.J. Pirola Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease Hepatology 53 2011 1883 1894
41. C.J. Willer, S. Sanna, A.U. Jackson, A. Scuteri, L.L. Bonnycastle, and R. Clarke Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat Genet 40 2008 161 169 (Pubitemid 351171403)
42. K. Kantartzis, A. Peter, F. Machicao, J. Machann, S. Wagner, and I. Konigsrainer Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene Diabetes 58 2009 2616 2623
43. Y.J. Zhou, Y.Y. Li, Y.Q. Nie, H. Yang, Q. Zhan, and J. Huang Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people J Gastroenterol Hepatol 25 2010 772 777
44. D.W. Jun, J.H. Han, E.C. Jang, S.H. Kim, S.H. Kim, and Y.J. Jo Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans Eur J Gastroenterol Hepatol 21 2009 667 672
45. H. Dong, J. Wang, C. Li, A. Hirose, Y. Nozaki, and M. Takahashi The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population J Hepatol 46 2007 915 920 (Pubitemid 46529040)
46. J. Song, K.A. Da Costa, L.M. Fischer, M. Kohlmeier, L. Kwock, and S. Wang Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD) FASEB J 19 2005 1266 1271 (Pubitemid 41113723)
47. L. Carulli, I. Canedi, S. Rondinella, S. Lombardini, D. Ganazzi, and S. Fargion Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis Dig Liver Dis 41 2009 823 828
48. G. Musso, R. Gambino, and M. Cassader Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis J Nutr Biochem 21 2010 834 840
49. C.P. Oliveira, J.T. Stefano, A.M. Cavaleiro, M.A. Zanella Fortes, S.M. Vieira, and L.V. Rodrigues Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease J Gastroenterol Hepatol 25 2010 357 361
50. N.M. El-Koofy, H.M. El-Karaksy, I.M. Mandour, G.M. Anwar, M.S. El-Raziky, and A.M. El-Hennawy Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children Saudi J Gastroenterol 17 2011 265 270
51. C. Namikawa, Z. Shu-Ping, J.R. Vyselaar, Y. Nozaki, Y. Nemoto, and M. Ono Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis J Hepatol 40 2004 781 786 (Pubitemid 38507358)
52. M. Bohme, H. Grallert, A. Fischer, C. Gieger, I. Nitz, and I. Heid MTTP variants and body mass index, waist circumference and serum cholesterol level: Association analyses in 7582 participants of the KORA study cohort Mol Genet Metab 95 2008 229 232
53. K.F. Petersen, S. Dufour, A. Hariri, C. Nelson-Williams, J.N. Foo, and X.M. Zhang Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease N Engl J Med 362 2010 1082 1089
54. J. Kozlitina, E. Boerwinkle, J.C. Cohen, and H.H. Hobbs Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance Hepatology 53 2011 467 474
55. D. Corella, M. Guillen, C. Saiz, O. Portoles, A. Sabater, and J. Folch Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus J Lipid Res 43 2002 416 427 (Pubitemid 34252272)
56. X. Peng, L. Zhang, Q. Wang, and X. Cui [Study on the relationship between FABP2 Ala54Thr polymorphism and the risk of non-alcoholic fatty liver diseases] Wei Sheng Yan Jiu 38 2009 401 404
57. R. Aller, D.A. De Luis, L. Fernandez, F. Calle, B. Velayos, and O. Izaola Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease Eur Rev Med Pharmacol Sci 13 2009 357 364
58. T. Zhao, J. Zhao, and W. Yang Association of the fatty acid-binding protein 2 gene Ala54Thr polymorphism with insulin resistance and blood glucose: a meta-analysis in 13451 subjects Diabetes Metab Res Rev 26 2010 357 364
59. T. Zhao, J. Zhao, J. Lv, and M. Nzekebaloudou Meta-analysis on the effect of the Ala54Thr polymorphism of the fatty acid-binding protein 2 gene on body mass index Nutr Metab Cardiovasc Dis 21 2011 823 829
60. T. Zhao, M. Nzekebaloudou, and J. Lv Ala54Thr polymorphism of fatty acid-binding protein 2 gene and fasting blood lipids: a meta-analysis Atherosclerosis 210 2010 461 467
61. K. Kantartzis, F. Machicao, J. Machann, F. Schick, A. Fritsche, and H.U. Haring The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans Clin Sci (Lond) 116 2009 531 537
62. S.K. Coudreau, P. Tounian, G. Bonhomme, P. Froguel, J.P. Girardet, and B. Guy-Grand Role of the DGAT gene C79T single-nucleotide polymorphism in French obese subjects Obes Res 11 2003 1163 1167 (Pubitemid 41127368)
63. E.H. Ludwig, R.W. Mahley, E. Palaoglu, S. Ozbayrakci, M.E. Balestra, and I.B. Borecki DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women Clin Genet 62 2002 68 73 (Pubitemid 36372699)
64. A. Kotronen, H. Yki-Jarvinen, A. Aminoff, R. Bergholm, K.H. Pietilainen, and J. Westerbacka Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts Eur J Endocrinol 160 2009 593 602
65. Y. Nozaki, T. Saibara, Y. Nemoto, M. Ono, N. Akisawa, and S. Iwasaki Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis Alcohol Clin Exp Res 28 8 Suppl 2004 Proceedings: 106S-110S
66. S. Morcillo, F. Cardona, G. Rojo-Martinez, M.C. Almaraz, I. Esteva, and M.S. Ruiz-De-Adana Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2) Clin Endocrinol (Oxf) 68 2008 102 107 (Pubitemid 350243489)
67. N. Kurokawa, E.H. Young, Y. Oka, H. Satoh, N.J. Wareham, and M.S. Sandhu The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals Int J Obes (Lond) 32 2008 1240 1249
68. D. Corella, M. Guillen, O. Portoles, J.V. Sorli, V. Alonso, and J. Folch Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation J Intern Med 250 2001 348 360 (Pubitemid 32955620)
69. N. Iwamoto, Y. Ogawa, S. Kajihara, A. Hisatomi, T. Yasutake, and T. Yoshimura Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver Clin Chim Acta 314 2001 85 91 (Pubitemid 33079186)
70. A.P. Gjesing, G. Andersen, K.S. Burgdorf, K. Borch-Johnsen, T. Jorgensen, and T. Hansen Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects Diabetologia 50 2007 563 568 (Pubitemid 46215499)
71. M.S. Jalba, G.G. Rhoads, and K. Demissie Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis Obesity (Silver Spring) 16 2008 2096 2106
72. Q. Zhan, Y.Y. Li, Y.Q. Nie, Y.J. Zhou, Y.L. DU, and W.H. Sha [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease] Zhonghua Gan Zang Bing Za Zhi 16 2008 375 378
73. A. Cenarro, M. Artieda, C. Gonzalvo, E. Merino-Ibarra, R. Aristegui, and A. Ganan Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response Am Heart J 150 2005 1154 1162 (Pubitemid 41773516)
74. A. Isaacs, F.A. Sayed-Tabatabaei, O.T. Njajou, J.C. Witteman, and C.M. Van Duijn The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis J Clin Endocrinol Metab 89 2004 3858 3863 (Pubitemid 39071485)
75. A.T. Kraja, D. Vaidya, J.S. Pankow, M.O. Goodarzi, T.L. Assimes, and I.J. Kullo A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium Diabetes 60 2011 1329 1339
76. M.D. Demirag, H.I. Onen, M.Y. Karaoguz, I. Dogan, T. Karakan, and A. Ekmekci Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease Dig Dis Sci 52 2007 3399 3403 (Pubitemid 350077186)
77. D.M. Lee, S.O. Lee, B.S. Mun, H.S. Ahn, H.Y. Park, and H.S. Lee [Relation of apolipoprotein E polymorphism to clinically diagnosed fatty liver disease] Taehan Kan Hakhoe Chi 8 2002 355 362
78. A. Sazci, G. Akpinar, C. Aygun, E. Ergul, O. Senturk, and S. Hulagu Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis Dig Dis Sci 53 2008 3218 3224
79. M.H. Yang, H.J. Son, J.D. Sung, Y.H. Choi, K.C. Koh, and B.C. Yoo The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease Hepatogastroenterology 52 2005 1832 1835 (Pubitemid 41745641)
80. P.G. Anthopoulos, S.J. Hamodrakas, and P.G. Bagos Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls Mol Genet Metab 100 2010 283 291
81. S. Sookoian, G. Castano, C. Gemma, T.F. Gianotti, and C.J. Pirola Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease World J Gastroenterol 13 2007 4242 4248 (Pubitemid 47377164)
82. M. Garaulet, Y.C. Lee, J. Shen, L.D. Parnell, D.K. Arnett, and M.Y. Tsai CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids Am J Clin Nutr 90 2009 1466 1475
83. P. Dongiovanni, L. Valenti, R. Rametta, A.K. Daly, V. Nobili, and E. Mozzi Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease Gut 59 2010 267 273
84. J.B. McAteer, S. Prudente, S. Bacci, H.N. Lyon, J.N. Hirschhorn, and V. Trischitta The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects Diabetes 57 2008 1125 1130
85. N. Grarup, S.A. Urhammer, J. Ek, A. Albrechtsen, C. Glumer, and K. Borch-Johnsen Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects Diabetologia 49 2006 2097 2104 (Pubitemid 44168477)
86. R. Wang, D. Zhou, B. Xi, X. Ge, P. Zhu, and B. Wang ENPP1/PC-1 Gene K121Q Polymorphism Is Associated with Obesity in European Adult Populations: Evidence from A Meta-Analysis Involving 24 324 Subjects Biomed Environ Sci 24 2011 200 206
87. E. Morini, S. Prudente, E. Succurro, M. Chandalia, Y.Y. Zhang, and S. Mammarella IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of "low-frequency-low-risk" variants Diabetologia 52 2009 1852 1857
88. J.C. Florez, M. Sjogren, N. Burtt, M. Orho-Melander, S. Schayer, and M. Sun Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes Diabetes 53 2004 3313 3318 (Pubitemid 39564509)
89. K. Tokushige, E. Hashimoto, H. Noto, S. Yatsuji, M. Taniai, and N. Torii Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease J Gastroenterol 44 2009 976 982
90. Z.L. Wang, B. Xia, U. Shrestha, L. Jiang, C.W. Ma, and Q. Chen Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population J Endocrinol Invest 31 2008 1086 1091
91. G. Musso, R. Gambino, M.F. De, M. Durazzo, G. Pagano, and M. Cassader Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH Hepatology 47 2008 1167 1177 (Pubitemid 351547903)
92. V.W. Wong, G.L. Wong, S.W. Tsang, A.Y. Hui, A.W. Chan, and P.C. Choi Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people J Gastroenterol Hepatol 23 2008 914 921 (Pubitemid 351806578)
93. P. Perez-Martinez, J. Lopez-Miranda, C. Cruz-Teno, J. gado-Lista, Y. Jimenez-Gomez, and J.M. Fernandez Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men J Nutr 138 2008 1609 1614
94. J.L. Gonzalez-Sanchez, C.A. Zabena, M.T. Martinez-Larrad, C. Fernandez-Perez, M. Perez-Barba, and M. Laakso An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance Obes Res 13 2005 807 812
95. A.W. Tso, P.C. Sham, N.M. Wat, A. Xu, B.M. Cheung, and R. Rong Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study Diabetologia 49 2006 1806 1815 (Pubitemid 44025035)
96. Yu Z, Han S, Cao X, Zhu C, Wang X, Guo X. Genetic Polymorphisms in Adipokine Genes and the Risk of Obesity: A Systematic Review and Meta-Analysis. Obesity (Silver Spring). 2011 Jun 9. doi:10.1038/oby.2011.148.
97. P. Dongiovanni, R. Rametta, A.L. Fracanzani, L. Benedan, V. Borroni, and P. Maggioni Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study BMC Gastroenterol 10 2010 102
98. S. Chen, Y. Li, S. Li, and C. Yu A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio J Gastroenterol Hepatol 23 2008 1415 1418
99. J.W. Rey, A. Noetel, A. Hardt, A. Canbay, H. Alakus, and H.A. Zur Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma2 in patients with fatty liver diseases World J Gastroenterol 16 2010 5830 5837
100. G.V. Huguenin, and G. Rosa The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects Br J Nutr 104 2010 488 497
101. H.N. Gouda, G.S. Sagoo, A.H. Harding, J. Yates, M.S. Sandhu, and J.P. Higgins The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis Am J Epidemiol 171 2010 645 655
102. L.J. Scott, K.L. Mohlke, L.L. Bonnycastle, C.J. Willer, Y. Li, and W.L. Duren A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants Science 316 2007 1341 1345 (Pubitemid 46871655)
103. A. Tonjes, M. Scholz, M. Loeffler, and M. Stumvoll Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals Diabetes Care 29 2006 2489 2497 (Pubitemid 44912258)
104. J.L. Gonzalez Sanchez, R.M. Serrano, P.C. Fernandez, M. Laakso, and M.T. Martinez Larrad Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population Eur J Endocrinol 147 2002 495 501 (Pubitemid 35238145)
105. X. Huang, J. Zhao, and T. Zhao Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: a meta-analysis Atherosclerosis 215 2011 136 144
106. I. Barroso, J. Luan, M.S. Sandhu, P.W. Franks, V. Crowley, and A.J. Schafer Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes Diabetologia 49 2006 501 505 (Pubitemid 43277873)
107. G. Musso, R. Gambino, G. Pacini, G. Pagano, M. Durazzo, and M. Cassader Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH Hepatology 49 2009 426 435
108. J.L. Gonzalez-Sanchez, M.T. Martinez-Larrad, C. Zabena, M. Perez-Barba, and M. Serrano-Rios Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population Diabetologia 51 2008 1993 1997
109. C. Hu, R. Zhang, C. Wang, J. Wang, X. Ma, and X. Hou Variants from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1 SLC30A8 and IGF1 are associated with glucose metabolism in the Chinese PLoS One 5 2010 e15542
110. E. Ingelsson, C. Langenberg, M.F. Hivert, I. Prokopenko, V. Lyssenko, and J. Dupuis Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans Diabetes 59 2010 1266 1275
111. P.H. Liu, Y.C. Chang, Y.D. Jiang, W.J. Chen, T.J. Chang, and S.S. Kuo Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults J Clin Endocrinol Metab 94 2009 3575 3582
112. Z. Yang, J. Wen, X. Tao, B. Lu, Y. Du, and M. Wang Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people Mol Biol Rep 38 2011 1145 1150
113. J.A. Nettleton, N.M. McKeown, S. Kanoni, R.N. Lemaitre, M.F. Hivert, and J. Ngwa Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies Diabetes Care 33 2010 2684 2691
114. H. Onuma, Y. Tabara, R. Kawamoto, I. Shimizu, R. Kawamura, and Y. Takata The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population J Hum Genet 55 2010 600 604
115. J. Dupuis, C. Langenberg, I. Prokopenko, R. Saxena, N. Soranzo, and A.U. Jackson New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk Nat Genet 42 2010 105 116
116. R. Saxena, M.F. Hivert, C. Langenberg, T. Tanaka, J.S. Pankow, and P. Vollenweider Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge Nat Genet 42 2010 142 148
117. R. Saxena, B.F. Voight, V. Lyssenko, N.P. Burtt, P.I. de Bakker, and H. Chen Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 2007 1331 1336 (Pubitemid 46871653)
118. A. Haupt, C. Thamer, M. Heni, O. Tschritter, J. Machann, and F. Schick Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss Obesity (Silver Spring) 17 2009 1942 1945
119. A. Scherag, C. Dina, A. Hinney, V. Vatin, S. Scherag, and C.I. Vogel Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german stu*dy gro*ups PLoS Genet 6 2010 e1000916
120. D. Wang, J. Ma, S. Zhang, A. Hinney, J. Hebebrand, and Y. Wang Association of the MC4R V103I polymorphism with obesity: a Chinese case-control study and meta-analysis in 55,195 individuals Obesity (Silver Spring) 18 2010 573 579
121. C.J. Willer, E.K. Speliotes, R.J. Loos, S. Li, C.M. Lindgren, and I.M. Heid Six new loci associated with body mass index highlight a neuronal influence on body weight regulation Nat Genet 41 2009 25 34
122. R.J. Loos, C.M. Lindgren, S. Li, E. Wheeler, J.H. Zhao, and I. Prokopenko Common variants near MC4R are associated with fat mass, weight and risk of obesity Nat Genet 40 2008 768 775 (Pubitemid 351748863)
123. E.H. Young, N.J. Wareham, S. Farooqi, A. Hinney, J. Hebebrand, and A. Scherag The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals Int J Obes (Lond) 31 2007 1437 1441 (Pubitemid 47339918)
124. F. Geller, K. Reichwald, A. Dempfle, T. Illig, C. Vollmert, and S. Herpertz Melanocortin-4 receptor gene variant I103 is negatively associated with obesity Am J Hum Genet 74 2004 572 581 (Pubitemid 38325928)
125. N. Oruc, O. Ozutemiz, A. Berdeli, G. Ersoz, F. Gunsar, and Z. Karasu Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease Ann Hepatol 8 2009 116 119
126. H. Lu, J. Sun, L. Sun, X. Shu, Y. Xu, and D. Xie Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China J Gastroenterol Hepatol 24 2009 228 232
127. D.A. De Luis, S.M. Gonzalez, R. Aller, O. Izaola, and R. Conde Influence of Lys656Asn polymorphism of the leptin receptor gene on insulin resistance in nondiabetic obese patients J Diabetes Complications 22 2008 199 204 (Pubitemid 351545844)
128. O. Portoles, J.V. Sorli, F. Frances, O. Coltell, J.I. Gonzalez, and C. Saiz Effect of genetic variation in the leptin gene promoter and the leptin receptor gene on obesity risk in a population-based case-control study in Spain Eur J Epidemiol 21 2006 605 612 (Pubitemid 44546622)
129. M. Heo, R.L. Leibel, K.R. Fontaine, B.B. Boyer, W.K. Chung, and M. Koulu A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference Int J Obes Relat Metab Disord 26 2002 640 646 (Pubitemid 34499283)
130. M. Heo, R.L. Leibel, B.B. Boyer, W.K. Chung, M. Koulu, and M.K. Karvonen Pooling analysis of genetic data: the association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity Genetics 159 2001 1163 1178 (Pubitemid 34033458)
131. V. Paracchini, P. Pedotti, and E. Taioli Genetics of leptin and obesity: a HuGE review Am J Epidemiol 162 2005 101 114 (Pubitemid 41373535)
132. R. Aller, D.A. De Luis, O. Izaola, S.M. Gonzalez, R. Conde, and G.T. Alvarez G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients Ann Hepatol 9 2010 439 444
133. Z.W. Hu, H.B. Luo, Y.M. Xu, J.W. Guo, X.L. Deng, and Y.W. Tong Tumor necrosis factor - alpha gene promoter polymorphisms in Chinese patients with nonalcoholic fatty liver diseases Acta Gastroenterol Belg 72 2009 215 221
134. K. Tokushige, M. Takakura, N. Tsuchiya-Matsushita, M. Taniai, E. Hashimoto, and K. Shiratori Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis J Hepatol 46 2007 1104 1110 (Pubitemid 46669735)
135. L. Valenti, A.L. Fracanzani, P. Dongiovanni, G. Santorelli, A. Branchi, and E. Taioli Tumor necrosis factor alpha promoter polymorphisms and insulin
136. S.C. Sookoian, C. Gonzalez, and C.J. Pirola Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome Obes Res 13 2005 2122 2131
137. L. Qi, R.M. Van Dam, J.B. Meigs, J.E. Manson, D. Hunter, and F.B. Hu Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis Hum Mol Genet 15 2006 1914 1920 (Pubitemid 43821781)
138. L. Qi, C. Zhang, R.M. Van Dam, and F.B. Hu Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals J Clin Endocrinol Metab 92 2007 3618 3625 (Pubitemid 47435347)
139. P. Brun, I. Castagliuolo, A.R. Floreani, A. Buda, L. Blasone, and G. Palu Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region Gut 55 2006 1212 (Pubitemid 44085699)
140. J.M. Fernandez-Real, M. Broch, C. Richart, J. Vendrell, A. Lopez-Bermejo, and W. Ricart CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity J Clin Endocrinol Metab 88 2003 1780 1784 (Pubitemid 36623404)
141. Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, et al. The sod2 c47t polymorphism influences nafld fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol. 2011 Jul 11.[ahead of print].
142. R. Iwata, K. Baur, B. Stieger, J.C. Mertens, A.K. Daly, and P. Frei A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease Clin Sci (Lond) 120 2011 287 296
143. S. Sookoian, G. Castano, T.F. Gianotti, C. Gemma, and C.J. Pirola Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease J Nutr Biochem 20 2009 765 770
144. C.W. Wang, H.Y. Lin, S.J. Shin, M.L. Yu, Z.Y. Lin, and C.Y. Dai The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population Liver Int 31 2011 1326 1331
145. K. Nakayama, T. Bayasgalan, K. Yamanaka, M. Kumada, T. Gotoh, and N. Utsumi Large scale replication analysis of loci associated with lipid concentrations in a Japanese population J Med Genet 46 2009 370 374
146. D.S. Bille, K. Banasik, J.M. Justesen, C.H. Sandholt, A. Sandbaek, and T. Lauritzen Implications of Central Obesity-Related Variants in LYPLAL1, NRXN3 MSRA, and TFAP2B on Quantitative Metabolic Traits in Adult Danes PLoS One 6 2011 e20640
147. I.M. Heid, A.U. Jackson, J.C. Randall, T.W. Winkler, L. Qi, and V. Steinthorsdottir Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution Nat Genet 42 2010 949 960
148. K. Hotta, M. Nakamura, T. Nakamura, T. Matsuo, Y. Nakata, and S. Kamohara Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1 FTO and MC4R and their effect on visceral fat area in the Japanese population J Hum Genet 55 2010 738 742
149. C.M. Lindgren, I.M. Heid, J.C. Randall, C. Lamina, V. Steinthorsdottir, and L. Qi Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution PLoS Genet 5 2009 e1000508
150. J.S. Dunn, W.M. Mlynarski, M.G. Pezzolesi, M. Borowiec, C. Powers, and A.S. Krolewski Examination of PPP1R3B as a candidate gene for the type 2 diabetes and MODY loci on chromosome 8p23 Ann Hum Genet 70 2006 587 593 (Pubitemid 44173370)
151. X. Luo, Y. Zhang, X. Ruan, X. Jiang, L. Zhu, and X. Wang Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis Diabetes 60 2011 1435 1445
152. T.M. Teslovich, K. Musunuru, A.V. Smith, A.C. Edmondson, I.M. Stylianou, and M. Koseki Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713